1. Home
  2. AZTA vs CRI Comparison

AZTA vs CRI Comparison

Compare AZTA & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • CRI
  • Stock Information
  • Founded
  • AZTA 1978
  • CRI 1865
  • Country
  • AZTA United States
  • CRI United States
  • Employees
  • AZTA N/A
  • CRI N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • CRI Apparel
  • Sector
  • AZTA Technology
  • CRI Consumer Discretionary
  • Exchange
  • AZTA Nasdaq
  • CRI Nasdaq
  • Market Cap
  • AZTA 2.2B
  • CRI 2.0B
  • IPO Year
  • AZTA 1995
  • CRI 2003
  • Fundamental
  • Price
  • AZTA $41.51
  • CRI $52.80
  • Analyst Decision
  • AZTA Buy
  • CRI Hold
  • Analyst Count
  • AZTA 5
  • CRI 6
  • Target Price
  • AZTA $63.60
  • CRI $67.67
  • AVG Volume (30 Days)
  • AZTA 533.4K
  • CRI 1.6M
  • Earning Date
  • AZTA 11-12-2024
  • CRI 10-25-2024
  • Dividend Yield
  • AZTA N/A
  • CRI 6.06%
  • EPS Growth
  • AZTA N/A
  • CRI 15.51
  • EPS
  • AZTA N/A
  • CRI 6.33
  • Revenue
  • AZTA $656,323,000.00
  • CRI $2,842,254,000.00
  • Revenue This Year
  • AZTA $0.52
  • CRI N/A
  • Revenue Next Year
  • AZTA $6.49
  • CRI N/A
  • P/E Ratio
  • AZTA N/A
  • CRI $8.35
  • Revenue Growth
  • AZTA N/A
  • CRI N/A
  • 52 Week Low
  • AZTA $40.24
  • CRI $50.27
  • 52 Week High
  • AZTA $69.16
  • CRI $88.03
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 38.58
  • CRI 34.10
  • Support Level
  • AZTA $44.72
  • CRI $50.27
  • Resistance Level
  • AZTA $50.81
  • CRI $54.63
  • Average True Range (ATR)
  • AZTA 2.24
  • CRI 1.82
  • MACD
  • AZTA 0.04
  • CRI 0.06
  • Stochastic Oscillator
  • AZTA 5.78
  • CRI 34.94

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: